| | | | | | |
1 | NTRA | | 11.41% | United States | $6.18b | Diagnostics & Research |
2 | SRPT | | 6.74% | United States | $10.54b | Biotechnology |
3 | ALNY | Alnylam Pharmaceuticals Inc | 5.91% | United States | $26b | Biotechnology |
4 | RARE | | 5.02% | United States | $2.91b | Biotechnology |
5 | CRSP | | 4.78% | United States | $3.96b | Biotechnology |
6 | 1548 | | 4.7% | Hong Kong | | Biotechnology |
7 | TECH | | 4.63% | United States | $11.32b | Biotechnology |
8 | A | | 4.6% | United States | $33b | Diagnostics & Research |
9 | QGEN | | 4.52% | United States | $9.53b | Diagnostics & Research |
10 | BMRN | Biomarin Pharmaceutical Inc | 4.36% | United States | $17.17b | Biotechnology |
11 | MYGN | | 3.9% | United States | $1.33b | Diagnostics & Research |
12 | ARWR | Arrowhead Pharmaceuticals Inc | 3.88% | United States | $3.15b | Biotechnology |
13 | VRTX | Vertex Pharmaceuticals Inc | 3.67% | United States | $89b | Biotechnology |
14 | TXG | | 3.42% | United States | $4.82b | Health Information Services |
15 | VCYT | | 3.16% | United States | $1.83b | Biotechnology |
16 | BNTX | | 2.87% | United States | $28b | Biotechnology |
17 | RCKT | Rocket Pharmaceuticals Inc | 2.72% | United States | $1.21b | Biotechnology |
18 | BEAM | | 2.41% | United States | $1.90b | Biotechnology |
19 | GILD | | 2.36% | United States | $96b | Drug Manufacturers-General |
20 | ILMN | | 2.15% | United States | $24b | Diagnostics & Research |
21 | NTLA | Intellia Therapeutics Inc | 2.08% | United States | $3.27b | Biotechnology |
22 | MRNA | |